Kynam Capital Management, LP Concert Pharmaceuticals, Inc. Transaction History

Kynam Capital Management, LP

  • $953 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.34 - $5.84 $11.9 Million - $16 Million
2,747,308 Added 164.21%
4,420,349 $25.8 Million
Q3 2022

Nov 14, 2022
BUY
$4.27 - $7.2 $2.87 Million - $4.85 Million
673,041 Added 67.3%
1,673,041 $11.2 Million
Q2 2022

Aug 15, 2022
BUY
$2.8 - $6.36 $2.8 Million - $6.36 Million
1,000,000 New
1,000,000 $4.21 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email